News
4d
Clinical Trials Arena on MSNBioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma"BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma" was originally created and published by Clinical ...
Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age ...
Pancreatic adenocarcinoma incidence rose across all age groups, with the highest APC (4.35) observed in those aged 15-34 years, which was significantly higher than the APC in those aged ≥ 55 ...
Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food ...
Pancreatic adenocarcinoma incidence increased among all age groups. Most cases occurred among patients aged 55 years and older (n = 239,840), followed by those aged 35 to 54 years (n = 33,800) and ...
Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...
After resection of carcinoma of the colon McGrew, Laws and Cole 6 (1954) took smears from the lumen of the bowel at each end of the resected specimens and examined them by the Papanicolaou technic.
About The Study: The findings of this cohort study suggest that the incidence of pancreatic adenocarcinoma has increased among all age groups, whereas that of colorectal adenocarcinoma has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results